These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis. Liu W; Wu YH; Hu SY; Zhong CL; Gao ML; Liu DW; Wang HY; Chen MZ; Song YJ; Yang BZ; Zheng QS; Yao H; Qi XB; Li G Trials; 2016 Jul; 17():359. PubMed ID: 27465818 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of Bi Qi Capsules in combination with methotrexate in the treatment of rheumatoid arthritis: A protocol of double-blind randomized controlled trial. Ding W; Chen S; Shi X; Zhao Y Medicine (Baltimore); 2021 May; 100(20):e25790. PubMed ID: 34011040 [TBL] [Abstract][Full Text] [Related]
24. [Treating rheumatoid arthritis patients of Shen deficiency and cold invading syndrome by bushen quhan zhiwang decoction combined methotrexate: an evaluation of clinical efficacy and safety]. Wang JM; Tao QW; Zhang YZ; Xu Y; Yan XP Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 May; 33(5):614-8. PubMed ID: 23905378 [TBL] [Abstract][Full Text] [Related]
25. Association between tongue appearance in Traditional Chinese Medicine and effective response in treatment of rheumatoid arthritis. Jiang M; Zha Q; Lu C; He Y; Lu A Complement Ther Med; 2011 Jun; 19(3):115-21. PubMed ID: 21641515 [TBL] [Abstract][Full Text] [Related]
26. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Strand V; Cohen S; Schiff M; Weaver A; Fleischmann R; Cannon G; Fox R; Moreland L; Olsen N; Furst D; Caldwell J; Kaine J; Sharp J; Hurley F; Loew-Friedrich I Arch Intern Med; 1999 Nov; 159(21):2542-50. PubMed ID: 10573044 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Qiwei Tongbi Oral Liquid in Patients with Stable Long-Standing Rheumatoid Arthritis. Lu W; Fang L; Zhang J Biomed Res Int; 2021; 2021():3930800. PubMed ID: 34725638 [TBL] [Abstract][Full Text] [Related]
28. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial. Song YW; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Baek HJ; Kim HA; Suh Y; Kang SW; Lee YJ; Jung HG Clin Ther; 2007 May; 29(5):862-873. PubMed ID: 17697905 [TBL] [Abstract][Full Text] [Related]
29. [Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine]. He YT; Zha QL; Yu JP; Tan Y; Lu C; Lu AP Zhong Xi Yi Jie He Xue Bao; 2008 Jan; 6(1):32-6. PubMed ID: 18184543 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of GuiZhi-ShaoYao-ZhiMu Decoction for Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Daily JW; Zhang T; Cao S; Park S J Altern Complement Med; 2017 Oct; 23(10):756-770. PubMed ID: 28609129 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. Li Z; Zhang F; Kay J; Fei K; Han C; Zhuang Y; Wu Z; Hsia EC Int J Rheum Dis; 2016 Nov; 19(11):1143-1156. PubMed ID: 26259617 [TBL] [Abstract][Full Text] [Related]
32. Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews. Scott DL; Ibrahim F; Farewell V; O'Keeffe AG; Ma M; Walker D; Heslin M; Patel A; Kingsley G Health Technol Assess; 2014 Oct; 18(66):i-xxiv, 1-164. PubMed ID: 25351370 [TBL] [Abstract][Full Text] [Related]
33. Will Chinese external therapy with compound Tripterygium wilfordii hook F gel safely control disease activity in patients with rheumatoid arthritis: design of a double-blinded randomized controlled trial. Jiang Q; Tang XP; Chen XC; Xiao H; Liu P; Jiao J BMC Complement Altern Med; 2017 Sep; 17(1):444. PubMed ID: 28870177 [TBL] [Abstract][Full Text] [Related]
34. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related]
35. [Correlations of clinical symptoms and treatment efficacy in patients with rheumatoid arthritis treated with Chinese herbal drugs or Western medicine]. Lü AP; He YT; Zha QL; Yan XP; Su L; Song YJ; Zeng SP; Liu W; Feng XH; Qian X; Zhu WH Zhong Xi Yi Jie He Xue Bao; 2005 Nov; 3(6):432-7. PubMed ID: 16282050 [TBL] [Abstract][Full Text] [Related]
36. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462 [TBL] [Abstract][Full Text] [Related]
37. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Huangqi Guizhi Wuwutang granule in patients with rheumatoid arthritis. Wang Y; Liu Y; Xi Z; Yu Y; Liu L; Mao J; Xiao L; Gu X; Yao M; Cui X; Shi Q; Wang Y; Liang Q Medicine (Baltimore); 2019 Mar; 98(11):e14888. PubMed ID: 30882703 [TBL] [Abstract][Full Text] [Related]
38. Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial. Louthrenoo W; Nilganuwong S; Nanagara R; Siripaitoon B; Collaud Basset S Clin Rheumatol; 2019 Sep; 38(9):2461-2471. PubMed ID: 31104217 [TBL] [Abstract][Full Text] [Related]
39. Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Schiff M; Takeuchi T; Fleischmann R; Gaich CL; DeLozier AM; Schlichting D; Kuo WL; Won JE; Carmack T; Rooney T; Durez P; Shaikh S; Hidalgo RP; van Vollenhoven R; Zerbini CAF Arthritis Res Ther; 2017 Sep; 19(1):208. PubMed ID: 28923098 [TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate. Fan W; Zhao DB; Hu SX; Xu HJ; Zhang X; Zhang MJ; Chen ZW; Zhang FX; Zhu P; Li XF; Bi LQ; Zhou B; Bao CD Rheumatol Int; 2014 Nov; 34(11):1519-27. PubMed ID: 24671501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]